68 filings
Page 2 of 4
8-K
asu5fi4je18h zedmb
19 May 23
Other Events
8:28am
8-K
ystj1 p1zr4
15 May 23
Taysha Gene Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
5:13pm
8-K
4ojulzdx98iw
27 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
rn61xx5e86a
28 Mar 23
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
4:12pm
8-K/A
u4pnf4wn
8 Mar 23
Departure of Directors or Certain Officers
5:11pm
8-K
ap2qwy2
31 Jan 23
Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy and a 2023 Corporate Outlook
4:09pm
8-K
v9rsdc16wtq
19 Jan 23
Departure of Directors or Certain Officers
4:02pm
8-K/A
sg4qwffjqqf0qp0gi6
6 Jan 23
Departure of Directors or Certain Officers
4:07pm
8-K
oixpy r4jwgc
22 Dec 22
Taysha Gene Therapies Announces Executive Leadership Changes
4:08pm
8-K
gtjnce upcqngdtv
8 Nov 22
Taysha Gene Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:06am
8-K/A
1dct ivtyz2
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
8-K
o9tu f5mq
27 Oct 22
Taysha Announces Pricing of Public Offering of Common Stock
5:18pm
8-K
yi9wrjt8qzcf8t56dba
25 Oct 22
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock
4:38pm
8-K
fd3wm
25 Oct 22
Astellas and Taysha Gene Therapies Announce
8:01am
8-K
u7e1j3dr5s44m
9 Sep 22
Regulation FD Disclosure
4:55pm
8-K
w4g6zoabvmr
11 Aug 22
Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:17am
8-K
44i5u vpsxndy2g4f3f
21 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
ow5ectkqanme
16 May 22
Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
8-K
fytj5cgsgalno0j
31 Mar 22
Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
7:15am
8-K
6jyt7pccza4 3wnjh
31 Jan 22
Other Events
7:16am